Viewing data from:

CELECOXIB

ANDA

CELECOXIB | A076898 | TEVA PHARMACEUTICALS USA INC

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CELEBREX(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Celecoxib (2023)

Total Spending

$198.0M

Total Claims

4,976,400

Beneficiaries

1,627,703

Avg Cost/Unit

$0.63

Spending Trend

$217.2M(2019)→$195.6M(2020)→$198.4M(2021)→$220.7M(2022)→$198.0M(2023)

YoY Change:-21.2%

5yr CAGR:-9.9%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain25 active DMFs4 inactive

24 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDCELECOXIB USP

DMF 166712003

MATRIX PHARMACORP PRIVATE LTDCELECOXIB USP

DMF 176972004

CADILA PHARMACEUTICALS LTDCELECOXIB USP

DMF 191552006

DR REDDYS LABORATORIES LTDCELECOXIB USP

DMF 219212008

AARTI DRUGS LTDCELECOXIB

DMF 231612009

LUPIN LTDCELECOXIB USP

DMF 235432010

ALEMBIC PHARMACEUTICALS LTDCELECOXIB USP

DMF 244192010

HETERO DRUGS LTDCELECOXIB

DMF 245572011

MICRO LABS LTDCELECOXIB USP

DMF 246862010

AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)CELECOXIB USP

DMF 254272012

JIANGXI SYNERGY PHARMACEUTICAL CO LTDCELECOXIB

DMF 255822011

MACLEODS PHARMACEUTICALS LTDCELECOXIB

DMF 257922012

PHARMAZELL INDIA PRIVATE LTDCELECOXIB USP

DMF 263562012

INTERQUIM SACELECOXIB

DMF 268862013

SAURAV CHEMICALS LTDCELECOXIB USP

DMF 273842015

APITORIA PHARMA PRIVATE LTDCELECOXIB USP

DMF 275012013

TIANJIN TIANYAO PHARMACEUTICALS CO LTDCELECOXIB USP

DMF 276352015

SOLARA ACTIVE PHARMA SCIENCES LTDCELECOXIB USP

DMF 280202014

SCINOPHARM TAIWAN LTDCELECOXIB USP

DMF 309262016

HIKAL LTDCELECOXIB

DMF 319712017

UNICHEM LABORATORIES LTDCELECOXIB USP

DMF 335792019

AURORE LIFE SCIENCES PRIVATE LTDCELECOXIB USP

DMF 340702019

HENAN DONGTAI PHARM CO LTDCELECOXIB

DMF 370922022

MICRO LABS LTDCELECOXIB USP (PROCESS-II)

DMF 372902022

CHEMECA DRUGS PRIVATE LTDCELECOXIB USP

DMF 375302023

NANO SYSTEMSInactiveCELECOXIB 200 MG FILM COATED TABLETS

DMF 149292000

ERREGIERRE SPAInactiveCELECOXIB USP-EP

DMF 196522006

HISUN PHARMACEUTICAL NANTONG CO LTDInactiveCELECOXIB USP

DMF 277442013

WATERSTONE PHARMACEUTICALS (HUBEI) CO LTDInactiveCELECOXIB

DMF 278722013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 2, 2014	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 30, 2014

No patent or exclusivity listings for this strength.

#002 — 100MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 30, 2014

#003 — 200MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 30, 2014

#004 — 400MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 30, 2014